Advertisement

Topics

Erytech closes $14.9mm PIPE concurrent with US IPO

14:40 EST 14 Nov 2017 | Elsevier Business Intelligence

Erytech Pharma SA (developing treatments for cancer and orphan diseases) netted €13.7mm ($14.9mm) through a private placeme...

Original Article: Erytech closes $14.9mm PIPE concurrent with US IPO

NEXT ARTICLE

More From BioPortfolio on "Erytech closes $14.9mm PIPE concurrent with US IPO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...